ATE483030T1 - Neue polynukleotid- und polypeptidsequenzen und deren verwendungen - Google Patents

Neue polynukleotid- und polypeptidsequenzen und deren verwendungen

Info

Publication number
ATE483030T1
ATE483030T1 AT03762257T AT03762257T ATE483030T1 AT E483030 T1 ATE483030 T1 AT E483030T1 AT 03762257 T AT03762257 T AT 03762257T AT 03762257 T AT03762257 T AT 03762257T AT E483030 T1 ATE483030 T1 AT E483030T1
Authority
AT
Austria
Prior art keywords
polypeptide sequences
new polynucleotide
polynucleotide
new
dega
Prior art date
Application number
AT03762257T
Other languages
English (en)
Inventor
Daniel Pereira
Original Assignee
Imclone Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imclone Llc filed Critical Imclone Llc
Application granted granted Critical
Publication of ATE483030T1 publication Critical patent/ATE483030T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
AT03762257T 2002-06-28 2003-06-30 Neue polynukleotid- und polypeptidsequenzen und deren verwendungen ATE483030T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39267502P 2002-06-28 2002-06-28
PCT/US2003/020601 WO2004003165A2 (en) 2002-06-28 2003-06-30 Novel polynucleotide and polypeptide sequences and uses thereof

Publications (1)

Publication Number Publication Date
ATE483030T1 true ATE483030T1 (de) 2010-10-15

Family

ID=30000915

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03762257T ATE483030T1 (de) 2002-06-28 2003-06-30 Neue polynukleotid- und polypeptidsequenzen und deren verwendungen

Country Status (9)

Country Link
US (1) US20070128595A1 (de)
EP (2) EP1572952B1 (de)
JP (1) JP4416650B2 (de)
AT (1) ATE483030T1 (de)
AU (1) AU2003261102A1 (de)
CA (1) CA2491083A1 (de)
DE (1) DE60334400D1 (de)
ES (1) ES2350828T3 (de)
WO (1) WO2004003165A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1578797A1 (de) * 2002-12-13 2005-09-28 Licentia Ltd. Das transmembranproteinamigo und dessen verwendungen
US8211630B2 (en) 2006-04-18 2012-07-03 Perseus Proteomics Inc. Diagnostic agent and therapeutic agent for pancreatic cancer
EP2051993A2 (de) * 2006-07-20 2009-04-29 Novartis Ag Amigo-2-hemmer für behandlung, diagnostizierung bzw. nachweis von krebs
JP2010280568A (ja) * 2007-09-21 2010-12-16 Perseus Proteomics Inc 肺癌、前立腺癌、乳癌、卵巣癌、及びメラノーマの診断薬および治療剤
JP2011001267A (ja) * 2007-10-17 2011-01-06 Univ Of Tokyo 大腸癌治療薬

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
WO2001053455A2 (en) * 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
ATE348108T1 (de) * 1999-03-08 2007-01-15 Genentech Inc Methode zum nachweis von tumoren
WO2001057190A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
JP2003135075A (ja) * 2001-11-05 2003-05-13 Research Association For Biotechnology 新規な全長ｃＤＮＡ
EP1578797A1 (de) * 2002-12-13 2005-09-28 Licentia Ltd. Das transmembranproteinamigo und dessen verwendungen

Also Published As

Publication number Publication date
DE60334400D1 (de) 2010-11-11
EP1572952A4 (de) 2007-08-29
ES2350828T3 (es) 2011-01-27
US20070128595A1 (en) 2007-06-07
WO2004003165A3 (en) 2006-07-20
JP2006508641A (ja) 2006-03-16
AU2003261102A1 (en) 2004-01-19
EP1572952A2 (de) 2005-09-14
WO2004003165A2 (en) 2004-01-08
WO2004003165A9 (en) 2004-04-01
CA2491083A1 (en) 2004-01-08
EP1572952B1 (de) 2010-09-29
AU2003261102A8 (en) 2004-01-19
EP2275573A1 (de) 2011-01-19
JP4416650B2 (ja) 2010-02-17

Similar Documents

Publication Publication Date Title
ATE444967T1 (de) Spezifische bindungsmittel von human angiopoietin-2
NZ593289A (en) Anti-neuropilin-1 antibodies for treating angiogenesis
ATE536188T1 (de) Fcgammariib-spezifische antikörper und verfahren zur verwendung davon
ATE541590T1 (de) Modifizierte antikörper-fragmente
TR200301846T2 (tr) Cripto bloke edici Antikorlar ve bu antikorların kullanımları.
DK1615952T3 (da) Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler
EA200701448A1 (ru) Специфически связывающаяся с крипто-антигеном человека молекула (варианты), композиция на ее основе (варианты), способ получения молекулы, способ лечения посредством молекулы (варианты) и способ ингибирования крипто-экспрессии в клетке больного
ATE378356T1 (de) Gangliosid-assoziierte rekombinante antikörper und deren verwendung bei der diagnose und behandlung von tumoren
ATE407698T1 (de) Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
DK1572087T3 (da) Antistoffer med cancerantigen TMEFF2 og anvendelser deraf
ATE483806T1 (de) Polynukleotide, welche für mitglieder der humanen b lymphozyten-aktivierendes antigen familie kodieren, und von diesen kodierte polypeptide
DE502005009389D1 (de) Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
EA200801174A1 (ru) Антитела-миметики glp-2, полипептиды, композиции, способы и применения
MXPA05007940A (es) Composiciones y metodos para el tratamiento del cancer usando igsf9 y liv-1.
ATE483030T1 (de) Neue polynukleotid- und polypeptidsequenzen und deren verwendungen
DE602006018424D1 (de) Peptide zum nachweis von ehrlichia ewingii antikörper
ATE494307T1 (de) Neoplasma-spezifische antikörper und deren verwendungen
DE60319135D1 (de) Peptide, die die heparinbindungsdomäne von vegf und vegfr-2 binden
ATE543833T1 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
ATE419861T1 (de) Peptide mit homing für lymphgefässtumor und ihre verwendung
EA200600956A1 (ru) Молекулы-антагонисты цитокинов
WO2004005351A3 (en) Neoplasm specific antibodies and uses thereof
WO2004007536A3 (en) Interactions of the epstein-barr virus protein ebna1, and uses thereof
DE602004006566D1 (de) Verfahren zur Diagnose und Behandlung von Metastasen und dafür nützliche Zusammensetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties